Provided by Tiger Trade Technology Pte. Ltd.

Reunion Neuroscience Inc.

1.12
0.0000
Volume:- -
Turnover:21.47K
Market Cap:13.12M
PE:-0.36
High:1.12
Open:1.12
Low:1.12
Close:1.12
52wk High:7.62
52wk Low:0.6303
Shares:11.72M
Float Shares:2.83M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0790
EPS(LYR):-3.0790
ROE:-86.35%
ROA:-26.50%
PB:0.84
PE(LYR):-0.36

Loading ...

Company Profile

Company Name:
Reunion Neuroscience Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, engages in developing new molecules to treat mental health conditions in North America. The company's lead asset, RE104, a proprietary, novel, and serotonergic psychedelic compound. It is also developing the RE200 series, which includes preclinical compounds with enhanced receptor selectivity to address additional therapeutic applications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.